These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 31278254)

  • 1. Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma.
    Czystowska-Kuzmicz M; Sosnowska A; Nowis D; Ramji K; Szajnik M; Chlebowska-Tuz J; Wolinska E; Gaj P; Grazul M; Pilch Z; Zerrouqi A; Graczyk-Jarzynka A; Soroczynska K; Cierniak S; Koktysz R; Elishaev E; Gruca S; Stefanowicz A; Blaszczyk R; Borek B; Gzik A; Whiteside T; Golab J
    Nat Commun; 2019 Jul; 10(1):3000. PubMed ID: 31278254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression.
    Bak SP; Alonso A; Turk MJ; Berwin B
    Mol Immunol; 2008 Dec; 46(2):258-68. PubMed ID: 18824264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.
    Steggerda SM; Bennett MK; Chen J; Emberley E; Huang T; Janes JR; Li W; MacKinnon AL; Makkouk A; Marguier G; Murray PJ; Neou S; Pan A; Parlati F; Rodriguez MLM; Van de Velde LA; Wang T; Works M; Zhang J; Zhang W; Gross MI
    J Immunother Cancer; 2017 Dec; 5(1):101. PubMed ID: 29254508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I.
    Liu Q; Zhang C; Sun A; Zheng Y; Wang L; Cao X
    J Immunol; 2009 May; 182(10):6207-16. PubMed ID: 19414774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. uPAR
    Porcelli L; Guida M; De Summa S; Di Fonte R; De Risi I; Garofoli M; Caputo M; Negri A; Strippoli S; Serratì S; Azzariti A
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33972390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The key role of IL-6-arginase cascade for inducing dendritic cell-dependent CD4(+) T cell dysfunction in tumor-bearing mice.
    Narita Y; Kitamura H; Wakita D; Sumida K; Masuko K; Terada S; Nakano K; Nishimura T
    J Immunol; 2013 Jan; 190(2):812-20. PubMed ID: 23248265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicles Present in Human Ovarian Tumor Microenvironments Induce a Phosphatidylserine-Dependent Arrest in the T-cell Signaling Cascade.
    Kelleher RJ; Balu-Iyer S; Loyall J; Sacca AJ; Shenoy GN; Peng P; Iyer V; Fathallah AM; Berenson CS; Wallace PK; Tario J; Odunsi K; Bankert RB
    Cancer Immunol Res; 2015 Nov; 3(11):1269-78. PubMed ID: 26112921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients.
    Landskron J; Helland Ø; Torgersen KM; Aandahl EM; Gjertsen BT; Bjørge L; Taskén K
    Cancer Immunol Immunother; 2015 Mar; 64(3):337-47. PubMed ID: 25416072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8
    Kanuma T; Yamamoto T; Kobiyama K; Moriishi E; Masuta Y; Kusakabe T; Ozasa K; Kuroda E; Jounai N; Ishii KJ
    J Immunol; 2017 Jun; 198(12):4707-4715. PubMed ID: 28507029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.
    Wei S; Kryczek I; Zou L; Daniel B; Cheng P; Mottram P; Curiel T; Lange A; Zou W
    Cancer Res; 2005 Jun; 65(12):5020-6. PubMed ID: 15958543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of Ovarian Cancer Patients Is Independent of the Presence of DC and T Cell Subsets in Ascites.
    Wefers C; Duiveman-de Boer T; Yigit R; Zusterzeel PLM; van Altena AM; Massuger LFAG; De Vries IJM
    Front Immunol; 2018; 9():3156. PubMed ID: 30687337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginase 1 is a key driver of immune suppression in pancreatic cancer.
    Menjivar RE; Nwosu ZC; Du W; Donahue KL; Hong HS; Espinoza C; Brown K; Velez-Delgado A; Yan W; Lima F; Bischoff A; Kadiyala P; Salas-Escabillas D; Crawford HC; Bednar F; Carpenter E; Zhang Y; Halbrook CJ; Lyssiotis CA; Pasca di Magliano M
    Elife; 2023 Feb; 12():. PubMed ID: 36727849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages.
    Song M; Yeku OO; Rafiq S; Purdon T; Dong X; Zhu L; Zhang T; Wang H; Yu Z; Mai J; Shen H; Nixon B; Li M; Brentjens RJ; Ma X
    Nat Commun; 2020 Dec; 11(1):6298. PubMed ID: 33293516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity.
    Giuntoli RL; Webb TJ; Zoso A; Rogers O; Diaz-Montes TP; Bristow RE; Oelke M
    Anticancer Res; 2009 Aug; 29(8):2875-84. PubMed ID: 19661290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of three molecular subtypes based on immune infiltration in ovarian cancer and its prognostic value.
    Liu J; Tan Z; He J; Jin T; Han Y; Hu L; Song J; Huang S
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33043974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of fusion cells from patient-derived ovarian carcinoma cells and dendritic cells as a vaccine for clinical use.
    Koido S; Nikrui N; Ohana M; Xia J; Tanaka Y; Liu C; Durfee JK; Lerner A; Gong J
    Gynecol Oncol; 2005 Nov; 99(2):462-71. PubMed ID: 16137749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial arginase-2 is a cell‑autonomous regulator of CD8+ T cell function and antitumor efficacy.
    Martí i Líndez AA; Dunand-Sauthier I; Conti M; Gobet F; Núñez N; Hannich JT; Riezman H; Geiger R; Piersigilli A; Hahn K; Lemeille S; Becher B; De Smedt T; Hugues S; Reith W
    JCI Insight; 2019 Nov; 4(24):. PubMed ID: 31751318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8α
    Wan S; Wang S; Weng L; Zhang G; Lin Z; Fei X; Zhang F; Yang F; Wang J; Cai Z
    J Immunol; 2018 Mar; 200(5):1651-1660. PubMed ID: 29358274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity.
    Peng P; Yan Y; Keng S
    Oncol Rep; 2011 Mar; 25(3):749-62. PubMed ID: 21181093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8(+) T activation attenuates CD4(+) T proliferation through dendritic cells modification.
    Chen D; Wang Y; Wang H; Wu Y; Xia S; Zhang M
    Cell Immunol; 2015 Aug; 296(2):138-48. PubMed ID: 26022412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.